{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=96", "query": { "intervention": "CTRL", "page": 96 }, "page_size": 10 }, "pagination": { "page": 96, "page_size": 10, "total_count": 26669, "total_pages": 2667, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=97&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=95&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-11T08:01:11.022Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02706236", "title": "Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatitis" ], "interventions": [ { "name": "Pancrelipase", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dartmouth-Hitchcock Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2016-04", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2018-02-27", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 1, "location_summary": "Lebanon, New Hampshire", "locations": [ { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT02706236" }, { "nct_id": "NCT00029211", "title": "A Trial of Echinacea in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Common Cold" ], "interventions": [ { "name": "Echinacea", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Center for Complementary and Integrative Health (NCCIH)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "2 Years to 11 Years" }, "enrollment_count": 600, "start_date": "2000-04", "completion_date": "2003-03", "has_results": false, "last_update_posted_date": "2006-08-18", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00029211" }, { "nct_id": "NCT04130464", "title": "Intraperitoneal Infusion of Analgesic for Postoperative Pain Management", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hysterectomy", "Gynecologic Surgical Procedures", "Narcotic Use", "Pain, Postoperative" ], "interventions": [ { "name": "Ropivacaine Infusion from ON-Q Pump", "type": "DRUG" }, { "name": "Ropivacaine + Ketorolac Infusion from ON-Q Pump", "type": "DRUG" }, { "name": "Normal Saline Infusion from ON-Q Pump", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ying Liu", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 120, "start_date": "2019-09-30", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04130464" }, { "nct_id": "NCT06071767", "title": "Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "HIV-1-infection" ], "interventions": [ { "name": "ChAdOx1.tHIVconsv1", "type": "BIOLOGICAL" }, { "name": "ChAdOx1.HIVconsv62", "type": "BIOLOGICAL" }, { "name": "MVA.tHIVconsv3", "type": "BIOLOGICAL" }, { "name": "MVA.tHIVconsv4", "type": "BIOLOGICAL" }, { "name": "Vesatolimod (VES)", "type": "DRUG" }, { "name": "GS-5423", "type": "DRUG" }, { "name": "GS-2872", "type": "DRUG" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2024-04-01", "completion_date": "2029-08-01", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 9, "location_summary": "San Diego, California • Atlanta, Georgia • Chicago, Illinois + 6 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06071767" }, { "nct_id": "NCT05886400", "title": "The Effects of Environmental Distractions on SCAT6 Outcomes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Concussion, Brain", "Mild Traumatic Brain Injury" ], "interventions": [ { "name": "SCAT6", "type": "OTHER" }, { "name": "Visual/ Auditory Distraction", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 48, "start_date": "2023-09-01", "completion_date": "2024-05-01", "has_results": false, "last_update_posted_date": "2024-06-24", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 1, "location_summary": "Bloomington, Indiana", "locations": [ { "city": "Bloomington", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05886400" }, { "nct_id": "NCT06045507", "title": "Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV", "HIV Pre-exposure Prophylaxis" ], "interventions": [ { "name": "MK-8527", "type": "DRUG" }, { "name": "Placebo to MK-8527", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 352, "start_date": "2023-11-08", "completion_date": "2025-02-12", "has_results": true, "last_update_posted_date": "2026-01-07", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 10, "location_summary": "North Hollywood, California • San Francisco, California • Hallandale, Florida + 7 more", "locations": [ { "city": "North Hollywood", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Hallandale", "state": "Florida" }, { "city": "Immokalee", "state": "Florida" }, { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06045507" }, { "nct_id": "NCT00089492", "title": "A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Optimized Background ARVs", "type": "DRUG" }, { "name": "enfuvirtide [Fuzeon]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 64, "start_date": "2004-07", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 21, "location_summary": "Hobson City, Alabama • Fountain Valley, California • Los Angeles, California + 16 more", "locations": [ { "city": "Hobson City", "state": "Alabama" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00089492" }, { "nct_id": "NCT00316771", "title": "A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "P38 Inhibitor (4) 150mg", "type": "DRUG" }, { "name": "P38 Inhibitor (4) 25mg", "type": "DRUG" }, { "name": "P38 Inhibitor (4) 300mg", "type": "DRUG" }, { "name": "P38 Inhibitor (4) 50mg", "type": "DRUG" }, { "name": "P38 Inhibitor (4) 75mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 374, "start_date": "2005-11", "completion_date": "2008-03", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Paradise Valley, Arizona • Tucson, Arizona + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00316771" }, { "nct_id": "NCT02286999", "title": "Probiotic Supplementation in Breastfed Newborn Infants", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis", "Food Allergies" ], "interventions": [ { "name": "B. infantis", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emanual Maverakis, MD", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Day", "maximum_age": "7 Days", "sex": "ALL", "summary": "1 Day to 7 Days" }, "enrollment_count": 0, "start_date": "2015-10", "completion_date": "2018-01", "has_results": false, "last_update_posted_date": "2019-11-15", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02286999" }, { "nct_id": "NCT07165028", "title": "A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metabolic Dysfunction-Associated Steatotic Liver Disease" ], "interventions": [ { "name": "Tirzepatide", "type": "DRUG" }, { "name": "Retatrutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4500, "start_date": "2025-10-15", "completion_date": "2032-08", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-11-11T08:01:11.022Z", "location_count": 141, "location_summary": "Tuscaloosa, Alabama • Chandler, Arizona • Gilbert, Arizona + 122 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07165028" } ] }